Early is Good exists because most people still find serious disease too late. We are building a new diagnostic platform that reads DNA, RNA, proteins and metabolites from one sample to find disease much earlier.
Saving lives at scale
Detect earlier. Treat smarter. Save lives.
Mission
Most people still discover serious disease too late. We are trying to move that moment years earlier.
Our platform does more than say "disease or no disease". It captures the biology behind it so doctors can see what is really happening and act with confidence.
If we are right, catching disease this early will feel obvious in ten years.
Detect earlier. Treat smarter. Save lives at scale.
Platform
A new category of diagnostics
One sample. One test. Many signals.
We read DNA, RNA, proteins and metabolites together from the same sample. There is no extraction and no amplification. Results come back in under four hours.
The goal is simple. Turn weak, noisy signals into clear answers that fit into standard clinical workflows.
Sample in → Multiomic analysis → Clear result
Products
Pipeline
Product
R&D
Analytical
Clinical
Regulatory
Launch
BCDx
Bladder cancer monitoring
Urine-based
Prostate Cancer
Liquid biopsy
With Mayo Clinic
This is the starting point. We plan to bring the same multiomic approach to other diseases where time makes all the difference.
Stay Updated
Get product updates
Be the first to know about clinical milestones, product launches, and company news.
We respect your privacy. Unsubscribe anytime.
News
Proof that real progress is happening
Early is Good has been covered in more than ten news stories, grants and partnership announcements, including:
NIH Phase 2 grant ($1.6M) for BCDx bladder cancer program
Clinical co-development with Mayo Clinic on prostate cancer
$4 million seed investment from Social Capital
Team
The people building Early is Good
Chamath Palihapitiya
Co-founder
Thakshila Liyanage, PhD
Co-founder and CEO
Asel Ananda, MSc
Co-founder and CTO
HL Ananda
Co-founder and COO
Eric H. Kim, MD
VP of Clinical Sciences
Ben Pacheco, PhD
Director of Technology Development
Fatimeh Nouri, PhD
Senior Scientist
Advisors
Vince Wong – Advisor, BioCrossroads
Hristos Kaimakliotis, MD – Clinical Advisor, Uro-oncologist, Indiana University
Clinton D. Bahler, MD – Clinical Advisor, Urologist, Indiana University
Saum Ghoddoussipour, MD – Clinical Advisor, Uro-oncologist, Rutgers Cancer Institute
Emanuel Petricoin, PhD – Scientific Advisor, Professor, George Mason University
Careers
Join us
We are building a small, focused team to rethink how and when disease is found. If we are right, this platform will become a core part of how serious disease is diagnosed in the future.
Senior Scientist – Immunoassay and PCR
Indianapolis, IN
Nanoparticle Bioconjugation Scientist
Indianapolis, IN
Senior Data Scientist, Integrative Omics
Indianapolis, IN
Business Development Manager
Indianapolis, IN
Contact
Start a conversation
Early is Good Inc
1210 Waterway Blvd, Suite 2000
Indianapolis, IN 46202